T. Rowe Price Associates »

Century Therapeutics shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Century Therapeutics (IPSC) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Century Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Century Therapeutics held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Century Therapeutics by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $26k 15k 1.75
2024-06-30 $38k 15k 2.55

More positions owned by T. Rowe Price Associates

Microsoft Corp Comm Stk (MSFT)
Apple Comm Stk (AAPL)
Nvidia Corporation Comm Stk (NVDA)
Amazon Comm Stk (AMZN)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Alphabet Comm Stk (GOOGL)
Unitedhealth Group Comm Stk (UNH)
Alphabet Comm Stk (GOOG)
Visa Comm Stk (V)
Mastercard Incorporated Comm Stk (MA)
Netflix Comm Stk (NFLX)
Tesla Comm Stk (TSLA)
Intuitive Surgical Comm Stk (ISRG)
Thermo Fisher Scientific Comm Stk (TMO)

View all positions for T. Rowe Price Associates

Top funds holding Century Therapeutics

VR Adviser
Boxer Capital
Casdin Capital
BlackRock
DAFNA Capital Management
Geode Capital Management
Tang Capital Management
Baker Bros. Advisors
Octagon Capital Advisors
Renaissance Technologies
Charles Schwab Investment Management
Northern Trust
Acadian Asset Management
Bank of New York Mellon
Jpmorgan Chase & Co

View all funds holding Century Therapeutics